Intravesical capsaicin for treatment of neurogenic bladder

OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder.

International journal of clinical practice·2014

Safety and tolerability of the β3 -adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised Phase III trials and of a 1-year randomised Phase III trial.

International journal of clinical practice·2014

Evidence available on the use of the selective β3-adrenoceptor agonist mirabegron for the treatment of overactive bladder.

Actas urologicas espanolas·2013

Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies.

International journal of clinical practice·2013

Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence.

Urology·2007

The prevalence of urinary incontinence.

Reviews in urology·2006

Most-favoured-nation pricing for prescription drugs in US Medicare: a cohort study.

Lancet (London, England)·2026

Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9-23 months in Uganda: a phase 4, single-blind, randomised clinical trial.

Lancet (London, England)·2026

Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastro-oesophageal junction adenocarcinoma (MATTERHORN): final results of overall survival and event-free survival by pathological response in a global, randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

Lancet (London, England)·2026

Wildfire smoke and health: current evidence, mechanisms, and future challenges.

Lancet (London, England)·2026

Deciphering Structure-Bubble-Mass Transfer Relationships in Water Electrolysis Through Electrode Morphology Regulation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Effectiveness of SWEEPS, XP-endo finisher and passive ultrasonic irrigation in calcium hydroxide removal: A micro-computed tomography study.

Lasers in medical science·2026

Degradation Mechanisms and Stabilization Strategies of Ag Nanoparticles and Atomically Precise Ag Nanoclusters for Electrochemical CO2 Reduction.

Small (Weinheim an der Bergstrasse, Germany)·2026

Rose Bengal-functionalized chitosan spheres as singlet oxygen generators for photodegradation of water contaminants and photodynamic inactivation.

Photochemistry and photobiology·2026

Suppression of Leidenfrost Rebound and Enhanced Heat Transfer by Ionic Wind.

ACS omega·2026

Evaporative Crystallization of Sodium Chlorate Droplets under Controlled Humidity in the Presence of a Static Magnetic Field.

ACS omega·2026

Related Experiment Videos

Intravesical capsaicin for treatment of neurogenic bladder

Related Concept Videos

OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder.

Safety and tolerability of the β3 -adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised Phase III trials and of a 1-year randomised Phase III trial.

Evidence available on the use of the selective β3-adrenoceptor agonist mirabegron for the treatment of overactive bladder.

Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies.

Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence.

The prevalence of urinary incontinence.

Most-favoured-nation pricing for prescription drugs in US Medicare: a cohort study.

Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9-23 months in Uganda: a phase 4, single-blind, randomised clinical trial.

Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

Wildfire smoke and health: current evidence, mechanisms, and future challenges.

Deciphering Structure-Bubble-Mass Transfer Relationships in Water Electrolysis Through Electrode Morphology Regulation.

Effectiveness of SWEEPS, XP-endo finisher and passive ultrasonic irrigation in calcium hydroxide removal: A micro-computed tomography study.

Degradation Mechanisms and Stabilization Strategies of Ag Nanoparticles and Atomically Precise Ag Nanoclusters for Electrochemical CO2 Reduction.

Rose Bengal-functionalized chitosan spheres as singlet oxygen generators for photodegradation of water contaminants and photodynamic inactivation.

Suppression of Leidenfrost Rebound and Enhanced Heat Transfer by Ionic Wind.

Evaporative Crystallization of Sodium Chlorate Droplets under Controlled Humidity in the Presence of a Static Magnetic Field.

Related Experiment Videos

Intravesical capsaicin for treatment of neurogenic bladder

Related Concept Videos

Related Articles